Date published: 2026-1-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

C18orf34 Inhibitors

Coiled-coil domain-containing 178 (CCDC178) is a protein that, as implied by its name, features a coiled-coil domain, which is a structural motif characterized by the intertwining of two or more alpha-helices into a supercoil structure. This motif is commonly involved in facilitating protein-protein interactions, suggesting that CCDC178 may play a role in a variety of cellular processes through its ability to form complexes with other proteins.The precise biological function of CCDC178 is not fully characterized, but proteins with coiled-coil domains are often implicated in various aspects of cell biology, including vesicle trafficking, cytoskeletal organization, and the regulation of gene expression. CCDC178, by virtue of its domain structure, may similarly be engaged in one or multiple such cellular activities.

The coiled-coil domain typically facilitates the oligomerization of proteins and is involved in the assembly of multiprotein complexes. Therefore, CCDC178 may participate in the formation of structures necessary for maintaining cell shape, intracellular transport, and cell signaling. The protein could be a component of the cytoskeleton or involved in the dynamics of cytoskeleton-associated processes, such as mitosis or cell motility.Given the general role of coiled-coil domain-containing proteins, CCDC178 might also be involved in intracellular trafficking pathways, such as the transport of vesicles between organelles like the Golgi apparatus and the plasma membrane. This process is critical for the secretion of proteins and lipids and for the retrieval of membrane components.Mutations or alterations in the expression of genes encoding coiled-coil domain proteins can have significant effects on cellular function and have been associated with various diseases. As such, understanding the specific interactions and functions of CCDC178 could have implications for the study of diseases where protein aggregation, trafficking, and cellular architecture are disrupted.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, a kinase involved in cell growth and proliferation. As CCDC178 might be involved in similar pathways, mTOR inhibition could indirectly affect processes where CCDC178 plays a role.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide inhibits protein synthesis in eukaryotic organisms. If CCDC178 is involved in protein synthesis regulation or dependent pathways, its function might be indirectly influenced by this inhibitor.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A is a histone deacetylase inhibitor. It alters chromatin structure and gene expression. As CCDC178 expression might be regulated epigenetically, this inhibitor could indirectly affect its expression levels.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor. Given that PI3K is involved in numerous signaling pathways, including those related to cell growth and survival, it could indirectly impact the function of CCDC178.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor. This kinase is involved in inflammatory responses and stress signaling, potentially interacting with pathways where CCDC178 is involved.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib inhibits proteasome activity. If CCDC178 is involved in protein degradation pathways or is regulated by ubiquitination, this inhibitor could indirectly affect its function.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

Thalidomide modulates the expression of various cytokines and growth factors. If CCDC178 is part of cytokine-regulated pathways, Thalidomide might have an indirect influence.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG132 is a proteasome inhibitor. Similar to Bortezomib, it could indirectly affect CCDC178 function if the protein is involved in protein degradation or ubiquitin-dependent processes.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a potent inhibitor of PI3K. By modulating PI3K activity, it might indirectly affect pathways or processes where CCDC178 is involved.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is an inhibitor of MEK, which could indirectly affect CCDC178 activity if the protein is involved in the MAPK/ERK pathway.